Translational Neurogenomics

Professor Eske Derks

Senior Group Leader

Research Focus

The Translational Neurogenomics Laboratory is headed by Professor Eske Derks. The group currently includes 10 members (one group leader, one postdoc, two research assistants, one visiting scientist, four PhD students and one undergraduate student).

The Translational Neurogenomics Laboratory has identified genetic risk factors for a range of neuropsychiatric conditions, including substance use disorders, schizophrenia, depression, and obsessive compulsive disorder. Researchers in this group use genetic data to address questions such as:

  • Which genetic variants in the DNA increase the risk of developing a neuropsychiatric disease?
  • What is the genetic overlap across different psychiatric disorders?
  • What are the downstream molecular consequences underlying statistical genetic associations?
  • Which existing drugs may be repurposed for prevention and treatment of neuropsychiatric diseases?

Gallery

The Translational Neurogenomics lab against a light grey background. (Left to right: Briar Wormington, Yingyan Yang, Yelena Reznikova, Damian Woodward, Eske Derks, Jackson Thorp, Lucia Bulmer, Pierre Youssef)
The Translational Neurogenomics lab at the 2024 GeneMappers Conference in Christchurch, New Zealand. (Left to right: Zac Gerring, Damian Woodward, Tingyan Yang, Tania Islam, Eske Derks, Yelena Reznikova, Briar Wormington)

Research Projects

Current Research Projects

Genetics of cannabis use

Functional genomics and tissue-specific gene regulation in the brain

Exploring genetic and phenotypic heterogeneity of depression


Research Team

Dr Jackson Thorp

Mx Briar Wormington

Damian Woodward

Tingyan Yang


Funding

  • NHMRC Investigator Grant L1 (Eske Derks)
  • NHMRC Investigator Grant EL1 (Jackson Thorp)

Publications

The genetic landscape of substance use disorders.

Gerring ZF, Thorp JG, Treur JL, Verweij KJH, Derks EM. Molecular Psychiatry. 2024 May 29.

doi: 10.1038/s41380-024-02547-z

PMID: 38811691

Identification of drug repurposing candidates for the treatment of anxiety: A genetic approach.

Woodward DJ, Thorp JG, Akosile W, Ong JS, Gamazon ER, Derks EM, Gerring ZF. Psychiatry Research. 2023 Aug; 326:115343.

doi: 10.1016/j.psychres.2023.115343

PMID: 37473490

The association between trauma exposure, polygenic risk and individual depression symptoms.

Thorp JG, Gerring ZF, Colodro-Conde L, Byrne EM, Medland SE, Middeldorp CM, Derks EM. Psychiatry Research. 2023 Mar; 321:115101.

doi: 10.1016/j.psychres.2023.115101

PMID: 36774750 

Read More


Further Information



External Collaborations
  • Professor Dorret Boomsma, Free University Amsterdam
  • Professor Jacqueline Vink, Radboud University, Nijmegen
  • Dr Florence Vorspan, Universités Paris Descartes – Paris Diderot
  • Professor Peter Visscher, University of Queensland
  • Professor Naomi Wray, University of Queensland
  • Professor Christel Middeldorp, University of Queensland
  • Dr Lea Davis, Vanderbilt University
  • Dr Eric Gamazon, Vanderbilt University
  • Professor Wim van den Brink, Academic Medical Center, Amsterdam
  • Professor Damiaan Denys, Academic Medical Center, Amsterdam
  • Dr Dorien Nieman, Academic Medical Center, Amsterdam
  • Dr Dirk Smit, Academic Medical Center, Amsterdam
  • Professor Koos Zwinderman, Academic Medical Center, Amsterdam
  • Professor Karien Stronks, Academic Medical Center, Amsterdam
  • Dr Henrike Galenkamp, Academic Medical Center, Amsterdam